Actualités TerrAscend Corp - TSND | Actions Toronto Stock Exchange

TerrAscend Reports Fourth Quarter and Full Year 2024 Financial Results

Fourth Quarter Net Revenue of $74.4 million, up 0.3% from $74.2 million in the third quarter of 2024 Fourth...

TerrAscend Announces Preliminary Fourth Quarter 2024 Financial Results and Schedules Earnings Conference Call

Net Revenue of $74.4 million, up 0.3% from $74.2 million in the third quarter of 2024 Gross Profit Margin of...

TerrAscend Appoints Lynn Gefen to Expanded Role of Chief People Officer

TORONTO, Nov. 26, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND...

TerrAscend Reports Third Quarter 2024 Financial Results

Net Revenue of $74.2 million and Gross Profit Margin of 48.8% 9th consecutive quarter of positive Cash Flow...

TerrAscend Enters Ohio with the Signing of Definitive Agreement to Acquire a Well Situated and Profitable Dispensary

Acquisition represents the Company’s initial entry into its sixth state; Intends to be a leader in Ohio through...

TerrAscend to Host Third Quarter 2024 Earnings Conference Call

TORONTO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND...

TerrAscend Closes on Remaining US$26 Million Draw of US$140 Million Debt Financing

TORONTO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND...

TerrAscend to Participate in the ATB Capital Markets 2024 Life Sciences Institutional Investor Conference on September 18th in NYC

TORONTO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND...

TerrAscend Announces $10 Million Share Repurchase Program

TORONTO, Aug. 20, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND...

TerrAscend Reports Second Quarter 2024 Financial Results

Net Revenue of $77.5 million, an increase of 7.5% year-over-year Cash Flow from continuing operations of $13.1...

TerrAscend Completes $140 Million Debt Financing

Non-dilutive financing bears a coupon of 12.75% with a four-year term and no prepayment penalties No material...

TerrAscend to Host Second Quarter 2024 Earnings Conference Call

TORONTO, July 10, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND...

TerrAscend Announces Results of Annual General Meeting

TORONTO, June 17, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND...

TerrAscend Celebrates Opening of The Apothecarium Nottingham, Maryland Dispensary

TORONTO, June 10, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND...

TerrAscend Celebrates the Opening of its New Detroit Dispensary, GAGE 313

TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

TerrAscend Corp (TSND)

Votre Hub pour des idées et discussions en direct en temps réel

TSND Actualités

TerrAscend Reports Fourth Quarter and Full Year 2024 Financial Results

TerrAscend Announces Preliminary Fourth Quarter 2024 Financial Results and Schedules Earnings Conference Call

TerrAscend Appoints Lynn Gefen to Expanded Role of Chief People Officer

TerrAscend Reports Third Quarter 2024 Financial Results

TerrAscend Enters Ohio with the Signing of Definitive Agreement to Acquire a Well Situated and Profitable Dispensary

TerrAscend to Host Third Quarter 2024 Earnings Conference Call

TerrAscend Closes on Remaining US$26 Million Draw of US$140 Million Debt Financing

TerrAscend to Participate in the ATB Capital Markets 2024 Life Sciences Institutional Investor Conference on September 18th in NYC

TerrAscend Announces $10 Million Share Repurchase Program

TerrAscend Reports Second Quarter 2024 Financial Results

TerrAscend Completes $140 Million Debt Financing

TerrAscend to Host Second Quarter 2024 Earnings Conference Call

TerrAscend Announces Results of Annual General Meeting

TerrAscend Celebrates Opening of The Apothecarium Nottingham, Maryland Dispensary

TerrAscend Celebrates the Opening of its New Detroit Dispensary, GAGE 313

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

TerrAscend Corp (TSND) Actualités

TerrAscend Corp (TSND)

Votre Hub pour des idées et discussions en direct en temps réel

TSND Actualités

TerrAscend Reports Fourth Quarter and Full Year 2024 Financial Results

TerrAscend Announces Preliminary Fourth Quarter 2024 Financial Results and Schedules Earnings Conference Call

TerrAscend Appoints Lynn Gefen to Expanded Role of Chief People Officer

TerrAscend Reports Third Quarter 2024 Financial Results

TerrAscend Enters Ohio with the Signing of Definitive Agreement to Acquire a Well Situated and Profitable Dispensary

TerrAscend to Host Third Quarter 2024 Earnings Conference Call

TerrAscend Closes on Remaining US$26 Million Draw of US$140 Million Debt Financing

TerrAscend to Participate in the ATB Capital Markets 2024 Life Sciences Institutional Investor Conference on September 18th in NYC

TerrAscend Announces $10 Million Share Repurchase Program

TerrAscend Reports Second Quarter 2024 Financial Results

TerrAscend Completes $140 Million Debt Financing

TerrAscend to Host Second Quarter 2024 Earnings Conference Call

TerrAscend Announces Results of Annual General Meeting

TerrAscend Celebrates Opening of The Apothecarium Nottingham, Maryland Dispensary

TerrAscend Celebrates the Opening of its New Detroit Dispensary, GAGE 313

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités